<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:News="http://www.bing.com/news/search?q=insomnia%26drug&amp;format=rss"><channel><title>insomnia&amp;drug - BingNews</title><link>http://www.bing.com/news/search?q=insomnia%26drug&amp;format=rss</link><description>Search results</description><image><url>http://www.bing.com/rsslogo.gif</url><title>insomnia&amp;drug</title><link>http://www.bing.com/news/search?q=insomnia%26drug&amp;format=rss</link></image><copyright>Copyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>New Guidance Clarifies the Role of Medications in Chronic Insomnia Care</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69ece6bafc0f4787bc3d9b812947d1a4&amp;url=https%3a%2f%2fwww.technologynetworks.com%2ftn%2fnews%2fnew-guidance-clarifies-the-role-of-medications-in-chronic-insomnia-care-412065&amp;c=4979394520505431103&amp;mkt=en-us</link><description>A new guideline states that CBT-I delivers strong, lasting improvements for insomnia. Combining CBT-I with medication may provide modest benefits for some patients. The guidelines highlight the ...</description><pubDate>Fri, 24 Apr 2026 09:19:00 GMT</pubDate><News:Source>Technology Networks</News:Source><News:Image>http://www.bing.com/th?id=ONUT.OkcCoHOBV0k2Sx8CT0T4lQ&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>640</News:ImageMaxWidth><News:ImageMaxHeight>360</News:ImageMaxHeight></item><item><title>Test of Insomnia Drug Bolsters Vanda's Plan</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69ece6bafc0f4787bc3d9b812947d1a4&amp;url=https%3a%2f%2fwww.washingtonpost.com%2farchive%2fbusiness%2f2006%2f11%2f16%2ftest-of-insomnia-drug-bolsters-vandas-plan%2fbaad6f75-462a-443a-9180-e41d4d51a89c%2f&amp;c=12749092898098222779&amp;mkt=en-us</link><description>A few years ago, drug giant Bristol-Myers Squibb Co. announced it was retooling its strategy, meaning a drug it was developing for insomnia was probably headed for the sidelines. Vanda Pharmaceuticals ...</description><pubDate>Wed, 15 Nov 2006 16:00:00 GMT</pubDate><News:Source>The Washington Post</News:Source></item><item><title>New Drug Approval for In-House Developed Anti-Insomnia Drug DAYVIGO (Lemborexant) in China</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69ece6bafc0f4787bc3d9b812947d1a4&amp;url=https%3a%2f%2fwww.nasdaq.com%2fpress-release%2fnew-drug-approval-house-developed-anti-insomnia-drug-dayvigo-lemborexant-china-2025&amp;c=15101229655484842998&amp;mkt=en-us</link><description>TOKYO, May 28, 2025 - (JCN Newswire) - - Eisai Co., Ltd. announced today that the in-house-discovered and developed orexin receptor antagonist DAYVIGO (generic name: lemborexant) has been approved in ...</description><pubDate>Wed, 28 May 2025 00:46:00 GMT</pubDate><News:Source>Nasdaq</News:Source></item><item><title>Report: Michael Jackson Begged For Insomnia Drug</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69ece6bafc0f4787bc3d9b812947d1a4&amp;url=https%3a%2f%2fwww.nbcconnecticut.com%2fnews%2fnational-international%2freport__michael_jackson_begged_for_insomnia_drug%2f2063257%2f&amp;c=3080585307932352821&amp;mkt=en-us</link><description>Michael Jackson was so distraught over persistent insomnia in recent months that he pleaded for a powerful sedative despite warnings it could be harmful, says a nutritionist who was working with the ...</description><pubDate>Tue, 30 Jun 2009 19:00:00 GMT</pubDate><News:Source>NBC Connecticut</News:Source></item><item><title>New guidelines highlight behavioral therapy for insomnia</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69ece6bafc0f4787bc3d9b812947d1a4&amp;url=https%3a%2f%2fmedicalxpress.com%2fnews%2f2026-04-guidelines-highlight-behavioral-therapy-insomnia.html&amp;c=16721514583091964763&amp;mkt=en-us</link><description>Combining medications with behavioral therapy to treat chronic insomnia might not be best for all patients, a new practice guideline says. Cognitive behavioral therapy for insomnia (CBT-I) works best ...</description><pubDate>Thu, 23 Apr 2026 17:00:00 GMT</pubDate><News:Source>Medical Xpress</News:Source><News:Image>http://www.bing.com/th?id=ONUT.OKwNH6fBnBIBGSKiGR626Q&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1280</News:ImageMaxWidth><News:ImageMaxHeight>854</News:ImageMaxHeight></item><item><title>FDA approves new insomnia drug</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69ece6bafc0f4787bc3d9b812947d1a4&amp;url=https%3a%2f%2fwww.beckershospitalreview.com%2fquality%2ffda-approves-new-insomnia-drug%2f&amp;c=7926536542827713445&amp;mkt=en-us</link><description>The U.S. Food and Drug Administration approved Belsomra (suvorexant) tablets for use as needed to treat insomnia. Belsomra is an orexin receptor antagonist and is the first approved drug of this type.</description><pubDate>Wed, 13 Aug 2014 17:00:00 GMT</pubDate><News:Source>Becker's Hospital Review</News:Source></item><item><title>Merck's Insomnia Drug Belsomra Clears Final DEA Hurdle</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69ece6bafc0f4787bc3d9b812947d1a4&amp;url=https%3a%2f%2fwww.raps.org%2fresource%2fmerck-s-insomnia-drug-belsomra-clears-final-dea-hu.html&amp;c=10945292927205227599&amp;mkt=en-us</link><description>The US Drug Enforcement Administration (DEA) has given a final and long-awaited approval to Merck to market its new insomnia drug Belsomra (suvorexant) as a Schedule IV drug. Belsomra is an orexin ...</description><pubDate>Tue, 26 Aug 2014 17:00:00 GMT</pubDate><News:Source>RAPS</News:Source></item><item><title>Insomnia Market Opportunity Assessment and Forecast Report 2022-2032: Z-Drugs Remain First-Line as Sparse Pipeline Adds $288 Million From Late-Stage Entrants ...</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69ece6bafc0f4787bc3d9b812947d1a4&amp;url=https%3a%2f%2fwww.marketwatch.com%2fpress-release%2finsomnia-market-opportunity-assessment-and-forecast-report-2022-2032-z-drugs-remain-first-line-as-sparse-pipeline-adds-288-million-from-late-stage-entrants-researchandmarkets-com-d8f6126c&amp;c=1792480889085294036&amp;mkt=en-us</link><description>The &quot;Insomnia: Opportunity Assessment and Forecast Update&quot; report has been added to ResearchAndMarkets.com's offering. This report covers the 7MM and provides an Excel-based forecast model for the ...</description><pubDate>Thu, 01 Jan 2026 13:51:00 GMT</pubDate><News:Source>MarketWatch</News:Source></item><item><title>Physician's choice of insomnia medication may be based on habit, new research shows</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69ece6bafc0f4787bc3d9b812947d1a4&amp;url=https%3a%2f%2fwww.news-medical.net%2fnews%2f20170215%2fPhysicians-choice-of-insomnia-medication-may-be-based-on-habit-new-research-shows.aspx&amp;c=81070099167982807&amp;mkt=en-us</link><description>Clinical decision-making is a complex process, driven by multiple factors, including social and psychological dynamics, peer pressure and even exposure to drug advertising. Now research from Harvard ...</description><pubDate>Tue, 14 Feb 2017 16:00:00 GMT</pubDate><News:Source>News Medical</News:Source></item><item><title>FDA approves generic versions of insomnia drug Ambien</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69ece6bafc0f4787bc3d9b812947d1a4&amp;url=https%3a%2f%2fwww.chron.com%2fnews%2fhouston-texas%2fhealth%2farticle%2ffda-approves-generic-versions-of-insomnia-drug-1535481.php&amp;c=2547005619444631946&amp;mkt=en-us</link><description>WASHINGTON — The first generic versions of the insomnia drug Ambien won federal approval Monday. The Food and Drug Administration said it approved versions of the immediate-release tablets made by 13 ...</description><pubDate>Mon, 23 Apr 2007 17:00:00 GMT</pubDate><News:Source>Houston Chronicle</News:Source></item></channel></rss>